跳至主要内容
临床试验/NCT06404411
NCT06404411尚未招募不适用

A Study of the Efficacy of Aerobic Exercise Based on Cardiopulmonary Exercise Test in the Rehabilitation of Patients With COVID-19-Related Myocardial Injury

Chengdu Sport University0 个研究点目标入组 40 人开始时间: 2024年6月30日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40
主要终点
VO2peak

研究概览

简要总结

A study of the efficacy of aerobic exercise based on cardiopulmonary exercise test in the rehabilitation of patients with COVID-19-related myocardial injury

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Between the ages of 18 and 65 years;
  • A history of new coronavirus infection;
  • Patients with a clinical diagnosis of COVID-19-related myocardial injury;
  • In the late stages of recovery from COVID-19-related myocardial injury, at least 3 months after diagnosis;
  • Negative cardiopulmonary exercise test;
  • After completing respiratory rehabilitation at our hospital in the previous period;
  • Normal blood biomarker tests and essentially normal 2D-STE, normal left ventricular systolic function, no spontaneous or inducible arrhythmias on electrocardiographic monitoring, and the patient's clinical status is stable, with most of the symptoms in significant remission, and the daily still activities are intolerant or do not reach the pre-disease exercise level;
  • Classification of nyha heart function of class I or II;
  • Voluntarily sign the informed consent form;
  • Not participating in other clinical trials.

排除标准

  • a previous history of coronary atherosclerotic heart disease and heart failure;
  • a combination of severe arrhythmia or cardiogenic shock;
  • a combination of severe hypertension, hypertrophic cardiomyopathy, valvular disease of moderate or greater severity, acute myocarditis or pericarditis;
  • a combination of any disease that severely affects limb movement, such as musculoskeletal disorders or severe hepatic or renal insufficiency
  • a combination of progressive malignant tumors, infectious diseases, bleeding disorders, autoimmune diseases, etc;
  • those who have serious mental illness and are unable to cooperate
  • those with incomplete clinical data;
  • those who have dropped out or terminated the trial by themselves.

结局指标

主要结局

VO2peak

时间窗: 12 weeks

All subjects were exercised in a plank fashion, using a modified Bruce protocol, in which the speed and incline were gradually increased by one level every 3 minutes during the test until the end of the exercise to reach the subject's sub-extreme volume of exercise, so that peak metabolic equivalents (METpeak), peak oxygen uptake (peak oxygen uptake, VO2peak), anaerobic threshold ( anaerobic threshold, AT), peak minute ventilation (VEpeak), breath reserve (BR), and peak oxygen pulse (VO2/HRpeak).

次要结局

  • METpeak(12 weeks)
  • BR(12 weeks)
  • Six-minute walk test distance, 6MWD(12 weeks)
  • SDANN(12 weeks)
  • mental health composite scale,MCS(12 weeks)
  • VEpeak(12 weeks)
  • RMSSD(12 weeks)
  • physical composite scale,PCS(12 weeks)
  • AT(12 weeks)
  • VO2/HRpeak(12 weeks)
  • SDNN(12 weeks)

研究者

发起方
Chengdu Sport University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ping Yang

Clinical Professor

Chengdu Sport University

相似试验